Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new page revision tag 'Revision: v3.4.2' has been added, and older notices including 'Revision: v3.4.1' and a government funding status notice have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedA new site-wide notice about a lapse in government funding and the NIH Clinical Center status has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and a new QC-status label ('Last Update Submitted that Met QC Criteria') with revision v3.4.0. The older QC label ('Last Update Submitted that met QC Criteria'), the No FEAR Act data item, and the older revision tag (v3.3.4) were removed or updated.SummaryDifference0.2%

- Check42 days agoChange DetectedA minor revision update was made to the page: Revision: v3.3.4 added and Revision: v3.3.3 removed, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now displays 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' link were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2, which does not affect the study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.